1. Listeria monocytogenes-associated respiratory infections: a study of 38 consecutive cases
- Author
-
M. Morgand, Mylène M. Maury, Caroline Charlier, Alexandre Leclercq, Pierre Thouvenot, Guillaume Vales, Hélène Bracq-Dieye, Marc Lecuit, Service des Maladies infectieuses et tropicales [CHU Necker], CHU Necker - Enfants Malades [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Centre National de Référence Listeria - National Reference Center Listeria (CNRL), Institut Pasteur [Paris]-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre collaborateur de l'OMS Listeria / WHO Collaborating Centre Listeria (CC-OMS / WHO-CC), Institut Pasteur [Paris]-Organisation Mondiale de la Santé / World Health Organization Office (OMS / WHO), Biologie des Infections - Biology of Infection, Université Paris Descartes - Paris 5 (UPD5), Funding was received from the Institut Pasteur, Santé Publique, France., Institut Pasteur [Paris] (IP)-Institut National de la Santé et de la Recherche Médicale (INSERM), Institut Pasteur [Paris] (IP)-Organisation Mondiale de la Santé / World Health Organization Office (OMS / WHO), and DIAKITE, andrée
- Subjects
Lung Diseases ,Male ,0301 basic medicine ,MESH: Respiratory Tract Infections/epidemiology ,MESH: Listeria monocytogenes/isolation & purification ,MESH: Empyema, Pleural/microbiology ,Pleural effusion ,MESH: Empyema, Pleural/etiology ,medicine.medical_treatment ,[SDV]Life Sciences [q-bio] ,MESH: Empyema, Pleural/drug therapy ,MESH: Listeriosis/epidemiology ,MESH: Listeriosis/drug therapy ,MESH: Aged, 80 and over ,listeriosis ,pleural effusion ,[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases ,MESH: Sepsis/etiology ,MESH: Anti-Bacterial Agents/therapeutic use ,Respiratory Tract Infections ,MESH: Respiratory Tract Infections/etiology ,Aged, 80 and over ,MESH: Aged ,Pleuropneumonia ,[SDV.MHEP] Life Sciences [q-bio]/Human health and pathology ,MESH: Middle Aged ,Respiratory infection ,Immunosuppression ,General Medicine ,Middle Aged ,MESH: Pneumonia, Bacterial/drug therapy ,MESH: Pneumonia, Bacterial/etiology ,MESH: Sepsis/epidemiology ,Anti-Bacterial Agents ,3. Good health ,[SDV] Life Sciences [q-bio] ,Infectious Diseases ,medicine.anatomical_structure ,[SDV.MP]Life Sciences [q-bio]/Microbiology and Parasitology ,MESH: Lung Diseases/microbiology ,[SDV.MHEP.MI] Life Sciences [q-bio]/Human health and pathology/Infectious diseases ,MESH: Pneumonia, Bacterial/microbiology ,Female ,MESH: Empyema, Pleural/epidemiology ,medicine.drug ,Adult ,Microbiology (medical) ,MESH: Pleuropneumonia/microbiology ,MESH: Pneumonia, Bacterial/epidemiology ,MESH: Lung Diseases/epidemiology ,medicine.medical_specialty ,030106 microbiology ,MESH: Pleuropneumonia/drug therapy ,03 medical and health sciences ,MESH: Listeriosis/complications ,Sepsis ,Internal medicine ,Pneumonia, Bacterial ,medicine ,Humans ,pneumonia ,MESH: Sepsis/drug therapy ,MESH: Lung Diseases/drug therapy ,[SDV.MP] Life Sciences [q-bio]/Microbiology and Parasitology ,MESH: Respiratory Tract Infections/drug therapy ,Empyema, Pleural ,Aged ,Retrospective Studies ,MESH: Pleuropneumonia/etiology ,MESH: Sepsis/microbiology ,Lung ,MESH: Humans ,business.industry ,MESH: Respiratory Tract Infections/microbiology ,MESH: Adult ,MESH: Retrospective Studies ,Amoxicillin ,medicine.disease ,Listeria monocytogenes ,[SDV.MP.BAC]Life Sciences [q-bio]/Microbiology and Parasitology/Bacteriology ,Empyema ,MESH: Male ,Pneumonia ,MESH: Lung Diseases/etiology ,Concomitant ,MESH: Listeriosis/microbiology ,MESH: Listeria monocytogenes/drug effects ,MESH: Pleuropneumonia/epidemiology ,[SDV.MP.BAC] Life Sciences [q-bio]/Microbiology and Parasitology/Bacteriology ,business ,MESH: Female ,[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology - Abstract
Listeria monocytogenes (Lm) is a foodborne human pathogen responsible for severe infections, including septicaemia, neurolisteriosis, and maternal-foetal and focal infections. Little is known about Lm-associated respiratory tract or lung infections.We conducted a retrospective study of culture-proven cases of Lm pleural infections and pneumonia reported to the French National Reference Centre for Listeria from January 1993 to August 2016.Thirty-eight consecutive patients with pleural infection (n = 32), pneumonia (n = 5), or both (n = 1) were studied; 71% of these were men. Median age was 72 (range 29-90). Two patients presented with concomitant neurolisteriosis. All patients but one reported at least one immunosuppressive condition (97%), with a median number of 2 (range 0-5), including 29% (8/28) with current exposure to immunosuppressive therapy and 50% (17/34) with ongoing neoplasia; 75% (21/28) reported previous pleural or pulmonary disease. Antibiotic therapy mostly consisted in amoxicillin (72%) associated with aminoglycoside in 32%. Chest-tube drainage was performed in 7/19 patients with empyema (37%); 25% of the patients (7/30) required intensive care management. In-hospital mortality reached 35% and occurred after a median time interval of 4 days (range 1-33 days). Three patients had recurrence of empyema (time interval of 1 week to 4 months after treatment completion). Altogether, only 13/31 patients (42%) diagnosed with Lm respiratory infection experienced an uneventful outcome at 2-year follow-up.Lm is a rare but severe cause of pneumonia and pleural infection in older immunocompromised patients, requiring prompt diagnosis and adequate management and follow-up.
- Published
- 2018
- Full Text
- View/download PDF